Total Return Price Chart

Historical Total Return Price Data

View and export this data back to 2011. Start Trial.
Date Value
November 03, 2026 36.39
November 02, 2026 36.40
October 30, 2026 36.39
October 29, 2026 36.39
October 28, 2026 36.39
October 27, 2026 36.40
October 26, 2026 36.38
October 23, 2026 36.42
October 22, 2026 36.34
October 21, 2026 36.33
October 20, 2026 36.38
October 19, 2026 36.34
October 16, 2026 36.34
October 15, 2026 36.33
October 14, 2026 36.40
October 13, 2026 36.31
October 12, 2026 36.35
October 09, 2026 36.31
October 08, 2026 36.39
October 07, 2026 25.20
October 06, 2026 24.76
October 05, 2026 25.05
October 02, 2026 25.21
October 01, 2026 25.01
September 30, 2026 25.05
Date Value
September 29, 2026 25.65
September 28, 2026 25.39
September 25, 2026 25.12
September 24, 2026 25.56
September 23, 2026 24.63
September 22, 2026 24.70
September 21, 2026 24.11
September 18, 2026 24.69
September 17, 2026 24.48
September 16, 2026 24.91
September 15, 2026 24.08
September 14, 2026 24.68
September 11, 2026 25.36
September 10, 2026 25.16
September 09, 2026 25.88
September 08, 2026 25.87
September 04, 2026 26.35
September 03, 2026 26.60
September 02, 2026 26.58
September 01, 2026 26.47
August 31, 2026 25.90
August 28, 2026 25.76
August 27, 2026 25.83
August 26, 2026 25.90
August 25, 2026 25.53

Total Return Price Definition

The total return price allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions.

Read full definition.

Total Return Price Range, Past 5 Years

View Total Return Price Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Return Price Benchmarks

View Total Return Price Benchmarks
Start Trial
Viatris, Inc. 18.99
Liquidia Corp. 48.85
Organon & Co. 13.85
ANI Pharmaceuticals, Inc. 72.08
Corcept Therapeutics, Inc. 77.65